throbber
Case: 1:16-cv-00651 Document #: 47-2 Filed: 11/08/16 Page 1 of 10 PageID #:2003
`Case: 1:16-cv—00651 Document #: 47-2 Filed: 11/08/16 Page 1 of 10 PagelD #:2003
`
`EXHIBIT 2
`
`EXHIBIT 2
`
`

`

`Case: 1:16-cv-00651 Document #: 47-2 Filed: 11/08/16 Page 2 of 10 PageID #:2004
`
`NOT FOR PUBLICATION
`
`UNITED STATES DISTRICT COURT
`DISTRICT OF NEW JERSEY
`
`HOSPIRA, INC., et al.
`
`CIVIL ACTION NO. 09-4591
`
`(MLC)
`
`DRAFT MARKMAN OPINION
`
`Plaintiffs,
`
`v.
`
`SANDOZ,
`
`INC., et al.
`
`Defendants.
`
`COOPER, District Judge
`
`The Court's Draft Construction of the Term "Intensive Care"
`
`Although the parties used the term "intensive care" in two
`
`definitions under United States Patent No. 6,716,867 ("the '867
`
`Patent"), they did not define it.
`
`(See id. at 4 ("The parties do
`
`not dispute the construction of any terms of the Patents-In-
`
`Suit.").) Because the Court has determined that it must define
`
`this term before resolving the Motions, it will now construe it.
`
`The Court begins by noting the "'heavy presumption' "that a
`
`claim term carries its ordinary and customary meaning." CCS
`
`Fitness Inc. v. Brunswick Corp., 288 F.3d 1359, 1366 (Fed. Cir.
`
`2002). The ordinary and customary meaning of a claim term is the
`
`meaning a "person of ordinary skill in the art in question" (a
`
`"POSITA") would assign such term on the patent's priority date.
`
`Phillips v. AWH Corp., 415 F.3d 1303, 1313 (Fed. Cir. 2005). A
`
`POSITA is deemed to interpret the claim term in the context of
`
`

`

`Case: 1:16-cv-00651 Document #: 47-2 Filed: 11/08/16 Page 3 of 10 PageID #:2005
`
`the entire patent, including the specification.
`
`Id. Claims
`
`terms carry their ordinary and customary meanings unless
`
`otherwise indicated in the patent specification or file history.
`
`Wolverine Worldwide, Inc. v. Nike, Inc., 38 F.3d 1192, 1196 (Fed.
`
`Cir. 1994).
`
`"To ascertain the scope and meaning of the asserted claims,
`
`we look to the words of the claims themselves, the specification,
`
`the prosecution history, and any relevant extrinsic evidence.ff
`
`'
`Retractable Techs., Inc. v. Becton, Dicksinon & Co., 653 F.3d
`
`1296, 1303 (Fed. Cir. 2011), rehearing and rehearing en bane
`
`denied, 659 F.3d 1369. The Court first looks to the intrinsic
`
`evidence of record, which includes the patent's claims,
`
`specification, and complete prosecution history. Markman, 52
`
`F.3d at 979. Such intrinsic evidence is the most significant
`
`source of the legally operative meaning of disputed claim
`
`language. Vitronic Corp. v. Conceptronic, Inc., 90 F.3d 1576,
`
`1583 (Fed. Cir. 1996). The specification is "always highly
`
`relevant to the claim construction analysis" and is "the single
`
`best guide to the meaning of a disputed term.ff Honeywell Int'l,
`
`Inc. v. ITT Indus., Inc., 452 F.3d 1312, 1318 (Fed. Cir. 2006)
`
`(internal quotation marks omitted) . The specification may
`
`contain an intentional disclaimer or a disavowal of claim scope
`
`by the inventor, whereby the inventor's intention, expressed in
`
`the specification, is dispositive. Phillips, 415 F.3d at 1316.
`
`2
`
`

`

`Case: 1:16-cv-00651 Document #: 47-2 Filed: 11/08/16 Page 4 of 10 PageID #:2006
`
`It is, however, improper to read a limitation from the
`
`specification into the claims. Teleflex, Inc. v. Ficosa N. Am.
`
`Corp., 299 F.3d 1313, 1326 (Fed. Cir. 2002).
`
`In some instances, the ordinary meaning of claim language,
`
`as understood by a POSITA, will be readily apparent to the Court
`
`after reviewing the intrinsic evidence.
`
`In such instances, claim
`
`construction will involve simply applying the widely accepted
`
`meanings of commonly understood words. Phillips, 415 F.3d at
`
`1314.
`
`In other circumstances, however, the Court may consider
`
`extrinsic evidence, such as "expert and inventor testimony,
`
`dictionaries, and learned treatises."
`
`Id.
`
`In general, such
`
`evidence is less reliable than its intrinsic counterparts.
`
`Id.
`
`at 1318. Notably, "heavy reliance on the dictionary divorced
`
`from the intrinsic evidence risks transforming the meaning of the
`
`claim term to the artisan into the meaning of the term in the
`
`abstract, out of its particular context, which is the
`
`specification."
`
`Id. at 1321. Further, unsupported assertions by
`
`experts as to the definition of a claim term are not useful, and
`
`the after-the-fact testimony of the inventor is accorded little
`
`if any weight in the claim construction inquiry.
`
`Id. at 1318.
`
`The term that actually appears in the '867 Patent claims is
`
`"intensive care unit." The parties have stipulated that an
`
`"intensive care unit" is "any setting that provides intensive
`
`care", but failed to define "intensive care".
`
`3
`
`

`

`Case: 1:16-cv-00651 Document #: 47-2 Filed: 11/08/16 Page 5 of 10 PageID #:2007
`
`The Court begins its claim construction inquiry by examining
`
`the intrinsic evidence of record. While the '867 Patent claims
`
`and related prosecution history do not help to define "intensive
`
`care", the'867 Patent specification provides some guidance.
`
`In
`
`the specification, Plaintiffs repeatedly refer to sedating
`
`patients that suffer from "critical illness" and sedating
`
`"critically ill patients".
`
`(See, e.g., '867 Patent at col. 1 at
`
`32, 43.)
`
`In Example 3, the specification details sixteen cases
`
`of sedation of "critically ill patients", describing Phase III
`
`trials of dexmedetomidine and "the benefits of dexmedetomidine
`
`sedation in critically ill patients."
`
`(Id. at col. 8 at line 47
`
`- col. 13 at line 54.) The specification provides that each of
`
`the sixteen "critically ill" patients was admitted to an "ICU",
`
`i.e., an intensive care unit, either preoperatively or
`
`postoperatively, and underwent some form of surgery.
`
`The
`
`specification does not, however, disclose whether these patients
`
`underwent surgery because they were "critically ill" or whether
`
`they were considered"critically ill" because they underwent
`
`surgery.
`
`It also fails to disclose the type of nursing care
`
`provided to these patients or, more generally, the quality of
`
`perioperative care provided, except inasmuch as it discloses the
`
`administration of dexmedetomidine, analgesics, and other
`
`sedatives.
`
`(Id.)
`
`4
`
`

`

`Case: 1:16-cv-00651 Document #: 47-2 Filed: 11/08/16 Page 6 of 10 PageID #:2008
`
`Because examination of the intrinsic evidence does not
`
`render a clear definition of "intensive care", the Court next
`
`turns to extrinsic evidence. During discovery, the parties
`
`solicited deposition regarding the definition of "intensive
`
`care". Romeo Bachand, one of the named inventors of the '867
`
`Patent, testified that "intensive care is a unit or a place where
`
`people get total care, human care, not procedural care."
`
`(Dkt.
`
`entry no. 229-12, Bachand Dep. at 164.) He explained that
`
`"intensive care[,] by its meaning in the [1990s]
`
`. had to do
`
`with care, and the care was with generally the ratio of patients
`
`to nurses taking care of the total patient."
`
`(Id. at 162.)
`
`Bachand further explained that preoperative and postoperative
`
`surgical care are more closely related to the underlying surgical
`
`procedure than to intensive care.
`
`(Id. at 163.)
`
`Plaintiffs' expert witness, Michael Ramsey, M.D., testified
`
`that a "setting that provides intensive care" "would be an area
`
`where the patient is intensively monitored for a period of time
`
`until the condition that had taken the patient to that unit had
`
`resolved or the need for intensive care monitoring, intensive
`
`monitoring had passed."
`
`(Dkt. entry no. 229-7, Ramsay Dep. at
`
`64.) Ramsay defined "intensive monitoring" as "[o]ne-on-one or
`
`two-to-one nursing care, continual monitoring of vital signs,
`
`immediate availability of support systems."
`
`(Id. at 65.) He
`
`testified that a patient could receive such monitoring in many
`
`5
`
`

`

`Case: 1:16-cv-00651 Document #: 47-2 Filed: 11/08/16 Page 7 of 10 PageID #:2009
`
`areas of a hospital, including an intensive care unit, an
`
`operating room, or a postoperative recovery area.
`
`(Id. at 67-68;
`
`dkt. entry no. 229-8, Ramsey Dep. II at 209-10.)
`
`The Sandoz Companies' expert witness, Jesse B. Hall, M.D.,
`
`opined that critical care settings are defined more so "by the
`
`nature of the patient than by the label over the geographic
`
`location in the hospital."
`
`(Dkt. entry no. 228-2, Ex. E, Hall
`
`Dep. at 24.) He stated:
`
`[I]f a patient is critically ill and is in the
`emergency department but must wait six hours for a bed
`to be available, we don't say they are denied critical
`care management while they're in the emergency room.
`The facility can be turned to that purpose for that
`patient's needs.
`The same thing occurs in the recovery room when
`there isn't an ICU bed or perhaps the ICUs need to be
`decompressed.
`It's common to just change the nursing
`ratios to make the circumstance of adequate critical
`care environment because the physicians can go there as
`needed, and the monitoring equipment exists to ahieve
`the same endpoints.
`It becomes a nursing coverage
`issue more than anything else.
`
`(Id. at 22.) Hall clarified that patients could thus receive
`
`intensive care in emergency rooms and postoperative recovery
`
`rooms.
`
`(Id. at 23.)
`
`The Court also sua sponte reviewed information provided by
`
`dictionaries and treatises. The Court, specifically, reviewed
`
`information in THE MERCK M.11.NUAL or D.::AGNosrs AND T:~::.:ATMSNT, 19th ed.
`
`("The Merck Manual") and STt:DMM1's Mr:1ncA1 01CTlONAtn ("Stedman's").
`
`The Merck Manual does not provide an explicit definition of
`
`6
`
`

`

`Case: 1:16-cv-00651 Document #: 47-2 Filed: 11/08/16 Page 8 of 10 PageID #:2010
`
`"intensive care"; indeed, the index entry for "intensive care"
`
`states only "see Critically ill patient".
`
`T:-i:!: M;:::r<.c:<: MA:.JJAL or
`
`DIAGNOSIS A:w TRE:ATME:NT 364 0 (Robert S. Porter, MD, et al. eds., 19th
`
`ed., 2011). The main entry for that section, i.e., "Critical
`
`Care Medicine", provides:
`
`Critical care medicine specializes in caring for
`the most seriously ill patients. These patients are
`best treated in an ICU staffed by experienced
`personnel.
`ICUs have a high nurse:patient ratio
`to provide the necessary high intensity of service,
`including treatment and monitoring of physiologic
`parameters.
`Supportive care for the ICU patient includes
`provision of adequate nutrition and prevention of
`infection, stress ulcers and gastritis, and pulmonary
`embolism. Because 15 to 25% of patients admitted to
`the ICUs die there, physicians should know how to
`minimize suffering help dying patients maintain
`dignity.
`
`Id. at 2243-44. The rest of that section sets forth the methods
`
`for procedures used to monitor and treat critically ill patients.
`
`See id. at 2243-2302.
`
`Stedman's defines "intensive care" as "management and care
`
`of critically ill patients".
`
`STSDMAN' s MED.::CAL D1CTIONAT£ 315 (28th
`
`ed., 2006).
`
`It defines "critical" as "[d)enoting a morbid
`
`condition in which death is possible."
`
`Id. at 462.
`
`It also
`
`defines an "intensive care unit" as "a hospital facility for
`
`provision of intensive nursing and medical care of critically ill
`
`patients, characterized by the high quality and quantity of
`
`continuous nursing and medical supervision and by use of
`
`7
`
`

`

`Case: 1:16-cv-00651 Document #: 47-2 Filed: 11/08/16 Page 9 of 10 PageID #:2011
`
`sophisticated monitoring and resuscitative equipment".
`
`Id. at
`
`2067 (emphasis added).
`
`Upon consideration of this evidence, and placing
`
`considerable weight on the intrinsic evidence, i.e., on the
`
`specification of the '867 Patent, the Court has determined that
`
`the term "intensive care" has two important aspects. First,
`
`First, "intensive care" involves "critically ill", patients.
`
`(See '867 Patent, col. 1 at line 32, 43, col. 8 at line 47 - col.
`
`13 at line 54). See also M.sH.cK MA:-1uA1 Or' D1AGNos1s A:m Tt<.±::ATMJ::Nr 2243-
`
`44; STED:1JAN'S MEDICAL DICI'lO>JARY 315, 462, 2067. Such "critically
`
`ill" patients are typically "the most seriously ill patients" who
`
`undergo surgery or other major medical procedures.
`
`(See '867
`
`Patent, col. 8 at line 47 - col. 13 at line 54). See also
`
`STSDMAN'S MEDICAL DICTlONM<Y 315, 462. These patients may die,
`
`either as a result of underlying medical conditions or as a
`
`result of the treatment for those conditions.
`
`(See '867 Patent,
`
`col. 8 at line 47 - col. 13 at line 54). See also STEDMAN' s
`
`MEDICAL 02:CTIONA!<.Y 315, 462.
`
`Second, intensive care is characterized by ongoing medical
`
`supervision. MERC:<: MANUAL OF' DIAGNos=s AND TREAT'.'IENT 2243-44. Such
`
`supervision typically includes a high nurse-to-patient ratio and
`
`continuous nursing care.
`
`(Bachand Dep. at 162-64; Hall Dep. at
`
`22-23 (noting that intensive care is characterized as "a nursing
`
`coverage issue more than anything else.") . ) See also MERC:« MANUAL
`
`8
`
`

`

`Case: 1:16-cv-00651 Document #: 47-2 Filed: 11/08/16 Page 10 of 10 PageID #:2012
`
`OF DIAGNOSIS AND T:<.:::ATMENT 2243. This supervision generally includes
`
`monitoring.
`
`Id.
`
`The Court will thus construe the term "intensive care" as
`
`follows:
`
`care provided to critically ill patients, typically
`characterized by high nursing-to-patient ratios,
`continuous medical supervision, and continuous
`monitoring.
`
`[DRAFT - NOT SIGNED]
`
`MARY L. COOPER
`United States District Judge
`
`9
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket